Earnings calendar/SXTPW
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)
60 DEGREES PHARMACEUTICALS, INC. (SXTPW) Q3 FY2026 (quarter ended ), quarterly report filed (accession 0001554855-26-002390): revenue $233,235, net income -$2.6M, diluted EPS -$0.75. Trailing four filed quarters ( to ): revenue $906,610, diluted EPS -$0.74. Figures from the SEC filing, in USD, as reported.
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter 60 DEGREES PHARMACEUTICALS, INC. has filed, from EvidInvest's standardized statements.
Period end
Sep 30, 2026
Q3 FY2026
EPS (diluted)
$-0.75
No estimate on record
Revenue
$233,235
As filed
Net income
$-2.6M
As filed
EPS YoY
+71.8%
vs quarter ended 2025-09-30
Revenue YoY
-46.7%
vs quarter ended 2025-09-30
Next report
Feb 15, 2027
Estimated from filing cadence
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-0.74
2025-12-31 through 2026-09-30
TTM revenue
$906,610
2025-12-31 through 2026-09-30
Filed quarters
19
On record here
Next revenue estimate
—
No estimate on record
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY |
|---|---|---|---|---|---|
| 2026-09-30Q3 FY2026 | 2026-11-16 | $-0.75 | $233,235 | +71.8% | -46.7% |
| 2026-06-30Q2 FY2026 | 2026-08-14 | $-0.90 | $207,898 | +82.0% | +106.0% |
| 2026-03-31Q1 FY2026 | 2026-05-15 | $-1.28 | $162,092 | +79.5% | -0.9% |
| 2025-12-31Q4 FY2025 | 2026-03-30 | $2.19 | $303,385 | +104.2% | +25.6% |
| 2025-09-30Q3 FY2025 | 2025-11-13 | $-2.66 | $437,602 | +8.9% | +223.4% |
| 2025-06-30Q2 FY2025 | 2025-08-13 | $-5.01 | $100,932 | +76.3% | -19.2% |
| 2025-03-31Q1 FY2025 | 2025-05-15 | $-6.25 | $163,552 | -441.5% | +54.8% |
| 2024-12-31Q4 FY2024 | 2025-03-27 | $-51.96 | $241,635 | -3.2% | +92.3% |
| 2024-09-30Q3 FY2024 | 2024-11-14 | $-2.92 | $135,293 | -132.0% | +164.3% |
| 2024-06-30Q2 FY2024 | 2024-08-14 | $-21.12 | $124,972 | -25.4% | +109.9% |
| 2024-03-31Q1 FY2024 | 2024-05-15 | $1.83 | $105,674 | +261.9% | +515.4% |
| 2023-12-31Q4 FY2023 | 2024-04-01 | $-50.34 | $125,681 | — | +438.1% |
| 2023-09-30Q3 FY2023 | 2023-11-20 | $9.13 | $51,188 | +1596.7% | -69.6% |
| 2023-06-30Q2 FY2023 | 2023-08-25 | $-16.84 | $59,532 | -1654.2% | +31.8% |
| 2023-03-31Q1 FY2023 | 2024-05-15 | $-1.13 | $17,172 | — | — |
| 2022-12-31Q4 FY2022 | 2024-04-01 | — | $-37,174 | — | — |
| 2022-09-30Q3 FY2022 | 2023-11-20 | $-0.61 | $168,185 | — | — |
| 2022-06-30Q2 FY2022 | 2023-08-25 | $-0.96 | $45,173 | — | — |
| 2022-03-31Q1 FY2022 | 2023-08-25 | — | — | — | — |
Need SXTPW data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.